{
    "root": "2ffe16bb-ca0d-c3d4-e063-6394a90a45b8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Potassium Chloride",
    "value": "20250310",
    "ingredients": [
        {
            "name": "HYDROGENATED COTTONSEED OIL",
            "code": "Z82Y2C65EA",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14334"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "POTASSIUM CHLORIDE",
            "code": "660YQ98I10",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32588"
        }
    ],
    "indications": {
        "text": "potassium chloride extended-release indicated treatment prophylaxis hypokalemia without metabolic alkalosis , patients dietary management potassium-rich foods diuretic dose reduction insufficient .",
        "doid_entities": [
            {
                "text": "hypokalemia (DOID:4500)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4500"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "monitor serum potassium adjust dosages accordingly . ( 2.1 ) serum potassium less 2.5 meq/l , intravenous potassium instead oral supplementation . ( 2.1 ) take meals glass water liquid . swallow tablets whole without crushing , chewing sucking . ( 2.1 ) treatment hypokalemia : doses range 40 100 meq/day divided doses . limit doses 40 meq per dose . ( 2.2 ) prevention hypokalemia : typical dose 20 meq per day . ( 2.2 )",
        "doid_entities": [
            {
                "text": "hypokalemia (DOID:4500)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4500"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "potassium chloride extended-release tablets , usp contains 750 mg potassium chloride ( equivalent 10 meq potassium respectively ) . ndc : 70518-2313-00 ndc : 70518-2313-01 ndc : 70518-2313-02 packaging : 30 1 blister pack packaging : 90 1 bottle plastic packaging : 30 1 bottle plastic store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense tight container child-resistant closure . keep tightly closed . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "potassium chloride contraindicated patients triamterene amiloride .",
    "indications_original": "Potassium chloride extended-release is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.",
    "contraindications_original": "Monitor serum potassium and adjust dosages accordingly. ( 2.1 ) If serum potassium is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation. ( 2.1 ) Take with meals and with a glass of water or other liquid. Swallow tablets whole without crushing, chewing or sucking. ( 2.1 ) Treatment of hypokalemia: Doses range from 40 to 100 mEq/day in divided doses. Limit doses to 40 mEq per dose. ( 2.2 ) Prevention of hypokalemia: Typical dose is 20 mEq per day. ( 2.2 )",
    "warningsAndPrecautions_original": "Potassium chloride extended-release tablets, USP contains 750 mg of potassium chloride (equivalent to 10 mEq of potassium respectively).\n                  NDC: 70518-2313-00\n                  NDC: 70518-2313-01\n                  NDC: 70518-2313-02\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 30 in 1 BOTTLE PLASTIC\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [See USP Controlled Room Temperature].\n                  Dispense in a tight container with a child-resistant closure.\n                  Keep tightly closed.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Potassium chloride is contraindicated in patients on triamterene and amiloride.",
    "drug": [
        {
            "name": "Potassium Chloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32588"
        }
    ]
}